Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
27 insider purchases on record · latest filing 2026-08-24.
Insiders have also filed 21 sale transactions at PTIX.